Impact of PCV7 on invasive pneumococcal disease among children younger than 5 years: a population-based study

American Journal of Public Health
Revathi R RamaniBao-Ping Zhu

Abstract

We examined the impact of the heptavalent pneumococcal conjugate vaccine (PCV7) on hospital discharge rates for invasive pneumococcal disease among Michigan children younger than 5 years old. After the introduction of PCV7, the hospital discharge rate for children younger than 1 years old was significantly lower than before introduction. We correlated the decreased rates with the introduction and rapid uptake of PCV7. Lack of change in the hospital discharge rates for other age groups likely represents a slower uptake of PCV7 compared with that for children aged younger than 1 year.

Citations

Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Samir S Shah, Adam J Ratner
Jun 1, 2006·American Journal of Public Health·Shannon StokleyAbigail Shefer
Mar 31, 2009·Academic Pediatrics·Peter G Szilagyi
Nov 6, 2007·The Journal of Infection·Craig Williams, Robert Masterton
Dec 18, 2013·International Journal of Clinical Practice·R A Stein
Feb 4, 2005·The Journal of Pediatrics·Sandra R ArnoldElaine E L Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.